Medical Radiation Exposures

Exposure to medical diagnostic tools involving radiation has increased dramatically among the U.S. population. DCEG researchers are assessing cancer risks associated with CT scan exposure in childhood. In addition, they are examining cancer risk associated with newer diagnostic radiologic examinations, such as high-dose nuclear medicine tests and fluoroscopically-guided interventional procedures. Researchers are studying radiation exposure from cancer treatment with the aim to quantify second cancers occurring among cancer survivors.

Diagnostic Radiation Exposures

Pediatric CT Scans and Cancer
A retrospective cohort study to evaluate the relationship between radiation exposure from CT scans conducted during childhood and adolescence and the subsequent development of cancer

Risk Assessment: Computer Tomography (CT) Scans and Screening Examinations
DCEG and colleagues have developed a state-of-the-art risk projection model for radiation-related lung cancer that takes into account the interaction with smoking

Tuberculosis Fluoroscopy
A study of site-specific cancer mortality among tuberculosis (TB) patients exposed to chest fluoroscopy

Radiation Treatment for Benign Diseases

Tonsil Irradiation and Risk of Thyroid and Other Cancers
A study of individuals irradiated during childhood for benign head and neck conditions and monitored for the risk of thyroid and other cancers

Hyperthyroidism I-131 Treatment
A study that compares cancer risks in patients treated for hyperthyroidism with Iodine-131 vs. antithyroid drugs or surgery

Late Effects of Radiotherapy, Chemotherapy and Other Cancer Treatment

Second Primary Cancers
DCEG investigators are actively engaged in research to address risks associated with treatment-related second cancers, lifestyle, environmental, and medical history factors, and genetic susceptibility

Childhood Cancer Survivor Study (CCSS)
A study of genetic susceptibility to radiotherapy among survivors of childhood cancer

Multiple Primary Cancers Monograph
To identify groups of cancer survivors that are at increased risk for multiple primary cancers, investigators led an effort to provide the first comprehensive population-based analysis of the risk of subsequent cancer in the U.S., resulting in a monograph

Second primary gastrointestinal (GI) cancers
A multi-center study of second primary gastrointestinal (GI) cancers among survivors of Hodgkin lymphoma and cancers of the testis, breast, and cervix. This study comprehensively investigates the dose-response following fractionated, higher dose radiation treatment and risk of secondary, non-hematologic malignancies associated with chemotherapy.